MedPath

A cross sectional study of Quality of Life in long-term pediatric survivors after autologous and allogeneic hematopoietic stem cell transplantatio

Not Applicable
Conditions
Hematopoietic stem cell trans- plantation targeted diseases such as hematological/malignant diseases, primary immunodeficiency and severe congenital metabolic disease
Registration Number
JPRN-UMIN000009546
Lead Sponsor
ate Effects / Quality of Life Working Group, the Japan Society for Hematopietic Cell Tranplantation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Patients who disapproved of TRUMP search. (2)Patients who are disqualified by his attending physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath